Anthony JohnsonDr. Tony Johnson joined Goldfinch Bio as president and chief executive officer in 2017.Prior to Goldfinch Bio, Tony was head of early clinical development and chief medical officer of the Innovative Medicines and Early…Dec 10, 2018Dec 10, 2018
Anthony JohnsonPrecision Medicine at the Forefront of Innovation in Kidney DiseaseI’ve recently returned from the 2018 American Society of Nephrology: Kidney Week meeting in San Diego and I’m so excited by the emerging…Dec 10, 2018Dec 10, 2018
Anthony JohnsonA new era of genetically-informed treatments for kidney diseases: Taking a page out of the oncology…By Anthony Johnson, President and Chief Executive Officer, Goldfinch Bio IncJun 29, 2018Jun 29, 2018